Our results showed that hypermethylation of SPOP promoter was detected in 31/118 CRC patients and this methylation-associated inactivation of the SPOP gene contributed to the CRC cell anti-apoptosis, suggesting that hypermethylation of SPOP could be a potential marker for CRC diagnosis. The gene discussed is SPOP; the disease is colorectal carcinoma.